<DOC>
	<DOCNO>NCT01200602</DOCNO>
	<brief_summary>RATIONALE : Megestrol acetate may help improve appetite lessen weight loss cause cancer . PURPOSE : This clinical trial study megestrol acetate treating weight loss anorexia young patient malignancy undergo radiation therapy and/or chemotherapy .</brief_summary>
	<brief_title>Megestrol Acetate Treating Weight Loss Anorexia Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : Proportion Patients Who Maintain Weight Experience Weight Gain . SECONDARY OBJECTIVES : BMI Trends , Caloric Intake , Weight Maintenance Over Time , Toxicity Profile Assessed NCI Common Toxicity Criteria Adverse Effects ( CTCAE ) v.4 . OUTLINE : Patients randomize 1 2 treatment arm . ARM A : Patients receive oral megestrol acetate 1-2 time ( 10 mg/kg dose daily 5 mg/kg dose twice daily ) daily 4 week . ARM B ( control ) : Patients observe weight loss gain 4 week . After completion study treatment , patient follow 12 week .</detailed_description>
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Body Weight Changes</mesh_term>
	<mesh_term>Megestrol</mesh_term>
	<mesh_term>Megestrol Acetate</mesh_term>
	<criteria>Any pediatric patient underlie diagnosis malignancy ( exclude hematological malignancy like leukemias lymphoma ) ≥5 % weight loss diagnosis primary malignancy ( must currently chemotherapy and/or radiation therapy schedule receive cancer therapy OR ≥5 % weight loss follow bone marrow transplant ( autologous allogeneic blood/bone marrow ) actively receive corticosteroid therapy Negative pregnancy test do = &lt; 7 day prior registration woman childbearing potential Receiving tube feeding parenteral nutrition Evidence ascites Current ( within past 28 day ) plan treatment adrenal steroid ( shortterm use dexamethasone around day intravenous chemotherapy allow protection emesis ) , androgens , progestational agent , appetite stimulant ( e.g. , dronabinol ) Known mechanical obstruction alimentary tract , malabsorption , intractable vomiting ( &gt; 5 episodes/week ) History unresectable brain tumor cancer metastatic brain History thromboembolic disease Insulinrequiring diabetes Congestive heart failure and/or uncontrolled hypertension Anticoagulation Previous history thrombosis ( personal immediate family ) Concurrent corticosteroid therapy ( except antiemetic )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>